What is the difference between a clinical trial and an expanded access program?

dylan 11 Jan 2024

1 mins read

share this post

The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.

However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options.

share this post

dylan 11 Jan 2024

Stay Up to Date

Signup to our newsletter for updates

more articles

view all blogs

From Diagnosis to Treatment: Managing Limb-Girdle Muscular Dystrophy

myTomorrows Team

17 Sep 2024

11 mins read

myTomorrows and CureLGMD2i Foundation Partnership

myTomorrows and the CureLGMD2i Foundation Partner to Ease Access to Clinical Trials for Patients with Limb Girdle Muscular Dystrophy Type 2I/R9

myTomorrows Team

4 Sep 2024

4 mins read

The Mighties at myTomorrowland 2024

myTomorrows Team

28 Aug 2024

3 mins read

myTomorrows and Pancreatic Cancer Europe Partnership

myTomorrows and Pancreatic Cancer Europe Partner to Support Pancreatic Cancer Patients in Accessing Clinical Trials

myTomorrows Team

27 Aug 2024

4 mins read

Group of physicians investigating new therapies for Type 1 Diabetes

Emerging Treatments for Type 1 Diabetes

myTomorrows Team

14 Aug 2024

6 mins read

Diversity, Equity and Inclusion, group of friends

Building Effective Diversity, Equity, and Inclusion Strategies in Clinical Trial Recruitment

myTomorrows Team

6 Aug 2024

9 mins read

myTomorrows Appoints AstraZeneca Executive Vice President Iskra Reic to its Board of Directors

myTomorrows Team

31 Jul 2024

3 mins read

myTomorrows Appoints Industry Leader Marshall Van Beurden as New Chief Technology Officer

myTomorrows Team

5 Jun 2024

3 mins read

A real-world data team member working at myTomorrows

Unlocking the potential of Real-World Evidence derived from Expanded Access Programs

myTomorrows Team

24 Apr 2024

8 mins read

myTomorrows and brainstrust Partner to Support the Brain Cancer Community in Accessing Clinical Trials

myTomorrows Team

4 Apr 2024

4 mins read